drugset
drugset / Trial / NCT06157450

Pharmacokinetics of ZSP1273 in Elder Participants

NCT06157450 ↗

Phase 1 Completed 32 enrolled Guangdong Raynovent Biotech Co., Ltd
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the safety, tolerability and PK of ZSP1273 in elder Participants

Timeline

Start
2023-10-11
Primary completion
2023-11-01
Completion
2023-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Onradivir Small molecule 600 mg Oral

Indications

No indication recorded.